Christina Vadeboncoeur

Investigator, CHEO Research Institute

Dr. Vadeboncoeur is a Pediatrician practicing Palliative Medicine at CHEO, Roger Neilson House and in the Ottawa community for over 15 years. Her research interests include standardization of the assessment and treatment of pain and other symptoms experienced by children with serious illness. She is involved in provincial research examining the benefits of specialized Pediatric Palliative Care for the child and family and also in utilization of health care resources.

Research Projects

  1. Medications to manage end-of-life symptoms in the immediate postpartum period


    There is a need for standardization of the medical management of infants born with life-limiting conditions whose parents choose to pursue palliative care.

  2. Medications to manage infant pain, distress and end-of-life symptoms in the immediate postpartum period


  3. Pediatric Project ECHO®: A Virtual Community of Practice to Improve Palliative Care Knowledge and Self-Efficacy among Interprofessional Health Care Providers


    Pediatric Project ECHO for Palliative Care has demonstrated feasibility and acceptability among community HCPs across Canada and was successful in achieving perceived changes in knowledge and self-efficacy. Although several performance-related outcomes were evaluated at six months, additional research is needed to determine the long-term impacts of ECHO for Palliative Care.

  4. Benefits of early referral to pediatric palliative care for a child with a rare disease


    This case is described to provide a voice for families who are caring for a child with an undiagnosed or life-limiting illness and especially for the families who won’t consider PPC either out of fear or not knowing it exists.

  5. Predictors of specialized pediatric palliative care involvement and impact on patterns of end-of-life care in children with cancer


    When available, SPPC, but not general palliative care, is associated with lower intensity care at the end of life for children with cancer. However, access remains uneven. These results provide the strongest evidence to date supporting the creation of SPPC teams.